搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
7 小时
Here is What Jim Cramer Likes Pfizer Inc. (NYSE:PFE)
The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to ...
13 小时
Early Study Shows Weight Loss Pill Amycretin May Lead to Significant Results Compared to ...
The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...
16 小时
15 Unhealthiest Countries in Europe
Here is our list of the 15 unhealthiest countries in Europe. Insider Monkey Score: 14.5 ...
Dagens News (US) on MSN
16 小时
Patients Claim Life-Altering Injuries from Ozempic and File Lawsuits
Hundreds of Americans have filed lawsuits in multiple states against pharmaceutical giants Novo Nordisk and Eli Lilly, ...
Opinion
Kennebec Journal
1 天
Opinion
Commentary: Who’s really keeping Ozempic and Wegovy prices so high?
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...
1 天
on MSN
Meet the people suing Ozempic for wrecking their bodies
Hundreds of Americans have jumped on a multi-state lawsuit alleging that the makers of Ozempic and Mounjaro caused ...
1 天
Senator Bernie Sanders grills the top executive of Novo Nordisk over high drug prices
The Senate investigation showed Americans pay $1,349 a month for the weight-loss drug Wegovy, which is priced at $92 in the United Kingdom.
1 天
Europe's STOXX 600 at all-time high as China-exposed firms revel in stimulus boost
Europe's STOXX 600 share index closed at a record high on Friday as companies and sectors exposed to China continued to rally ...
1 天
Bristol-Myers Squibb: Hold Rating Amid New Schizophrenia Drug Launch and Patent Expiries
Analyst Evan Seigerman from BMO Capital maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report) and increased the price ...
BioSpace
1 天
Lilly Is Not ‘Feeling the Bern’ on Drug Prices Like Novo: Why the Double Standard?
Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s ...
1 天
Sen. Bernie Sanders grills maker of Ozempic
On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.
1 天
Novo faces ‘Nokia risk’ as it fights Lilly’s homecourt advantage
The success of Eli Lilly’s Zepbound, a challenger to Novo’s Wegovy, has prompted comparisons to a similar scenario, when ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈